To include your compound in the COVID-19 Resource Center, submit it here.

In Lysando’s Artilysin tech, AiCuris sees means to evade antibiotic resistance

AiCuris believes it can bypass antibiotic resistance by using Lysando's platform to develop an array of phage-derived antibacterial proteins spanning broad and narrow

Read the full 238 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE